By Izzy Wood (Drug Target Review)2023-07-25T15:00:13
Machine learning (ML) presents a promising opportunity to revolutionize early cancer detection in primary care, addressing the challenges associated with diagnostic errors and improving patient outcomes. The potential of ML in this field is highlighted in a recent paper published in Oncoscience
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-20T13:00:00Z
2026-11-20T08:00:00Z
Contributor Dr Rahul Gupta, By Drug Target Review
2026-11-18T11:12:00Z
2026-11-17T09:31:00Z
2026-11-13T15:34:00Z
2026-11-02T07:00:00
Sponsored by Biointron
2026-08-20T08:43:00
Author Dr Daniel Tillett
2026-06-01T07:00:00
Contributor Dr Timothy O’Connor, By Drug Target Review
2026-10-01T06:30:00
Sponsored by Promega Corporation
2023-07-04T10:05:58
Sponsored by Revvity
2026-05-25T07:00:00
Contributor Professor Neville Sanjana
Site powered by Webvision Cloud